Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Amine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105001159A enables chiral phosphoric acid catalysis for quinoline-3-amine hydrogenation. Delivers high ee values and scalable pharmaceutical intermediate manufacturing solutions.
Patent CN101041638B reveals novel metal-free chiral amines. Discover cost-effective synthesis and high-purity supply for asymmetric catalysis applications.
Patent CN110551037B details a high-efficiency iridium/chiral diphosphine system for asymmetric hydrogenation, offering superior enantioselectivity for agrochemical intermediates.
Patent CN112824374B details a nickel-catalyzed asymmetric hydrogenation method for chiral amines, offering cost-effective alternatives to precious metals for pharmaceutical intermediates.
Patent CN102304007B reveals high-ee asymmetric hydrogenation using chiral Ru catalysts enabling cost reduction in pharmaceutical intermediate manufacturing with scalable processes.
Novel iridium catalyst system enables high-yield asymmetric hydrogenation for metolachlor intermediates, offering scalable cost reduction and supply reliability.
Patent CN114539328B reveals surfactant-promoted route enhancing yield and purity. Delivers supply chain stability and cost efficiency for global buyers.
Novel tertiary amine-thiourea catalyst enables high-yield asymmetric conjugate addition for scalable API intermediate production with superior enantioselectivity.
Patent CN111848322B details a novel organocatalytic resolution for axially chiral oxindole-substituted styrenes, offering high enantioselectivity and mild conditions for pharmaceutical intermediate manufacturing.
Patent CN116444400B reveals a novel Pd-catalyzed synthesis for high-purity chiral amines. Discover cost-effective manufacturing and scalable supply chain solutions.
Novel Pd-catalyzed synthesis offers high enantioselectivity. Reduces costs and improves supply chain reliability for pharmaceutical intermediates.
Patent CN113461589B details a novel one-step asymmetric Friedel-Crafts reaction for chiral 2,3-disubstituted indoleamines, offering significant cost reduction in API manufacturing.
Discover advanced axial chiral styrene tertiary amine thiourea catalysts offering superior enantioselectivity and mild reaction conditions for pharmaceutical intermediate manufacturing.
Patent CN112920053A reveals a safer, high-yield route for chiral amines used in asthma and cancer drugs, offering significant cost reduction and supply chain reliability for API manufacturers.
Patent CN113195460A details enantioselective iridium-catalyzed hydrogenation of oximes. This breakthrough offers cost reduction in agrochemical intermediate manufacturing and reliable supply chain solutions.
Patent CN112920053B details a mild, high-yield route for chiral amines used in asthma and oncology drugs, offering significant supply chain stability.
Patent CN112920053B reveals a scalable, high-purity route for chiral amines used in asthma and oncology APIs, offering significant cost and safety advantages.
Breakthrough chiral biaryl pyridoxamine catalyst enables high-yield asymmetric transamination with mild conditions, offering reliable supply chain for pharmaceutical intermediates.
Innovative synthesis of axial chirality vicinal diamines with simplified process, cost-effective raw materials, and scalable production for pharmaceutical intermediates supply chain optimization.
Patent CN102276376B introduces an efficient synthesis route eliminating chiral resolution, enhancing purity and reducing supply chain costs for pharmaceutical intermediates.